Details
Stereochemistry | ACHIRAL |
Molecular Formula | CO2 |
Molecular Weight | 44.0095 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C=O
InChI
InChIKey=CURLTUGMZLYLDI-UHFFFAOYSA-N
InChI=1S/CO2/c2-1-3
Carbon dioxide is a colorless gas occurring naturally in Earth's atmosphere. Carbon dioxide is a primary carbon source for life on Earth. It is produced by all aerobic organisms during metabolism of carbohydrates and lipids. Carbon dioxide is used in food industry as an acidity regulator and for production of carbonated soft drinks and soda water. In medicine, carbon dioxide is commonly used as an insufflation gas for minimally invasive surgery (laparoscopy, endoscopy, and arthroscopy) to enlarge and stabilize body cavities to provide better visibility of the surgical area. A mixture of carbon dioxide and oxygen is used for stimulation of breathing after apnea, in anesthetic procedures to increase the depth of respiration, to facilitate blind intubations in anesthetic practice.
CNS Activity
Sources: https://www.boconline.co.uk/internet.lg.lg.gbr/en/images/medical_carbon_dioxide410_56027.pdf?v=2.0
Curator's Comment: Carbon dioxide is naturally produced in all tissues.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseCarbon dioxide is used to stimulate respiration after a period of apnoea |
|||
Primary | Unknown Approved UseCarbon dioxide is used in chronic respiratory obstruction after it has been relieved |
|||
Palliative | Unknown Approved UseCarbon dioxide is used to increase cerebral blood flow in arteriosclerotic patients undergoing surgery |
PubMed
Title | Date | PubMed |
---|---|---|
Oxidative degradation of phenanthrene by the ligninolytic fungus Phanerochaete chrysosporium. | 1992 Jun |
|
Kinetics of chromium (VI) reduction by a type strain Shewanella alga under different growth conditions. | 2001 |
|
Prevention of caries by pulsed CO2 laser pre-treatment of enamel: an in-vitro study. | 2001 Dec |
|
On-line estimation of the metabolic burden resulting from the synthesis of plasmid-encoded and heat-shock proteins by monitoring respiratory energy generation. | 2001 Dec |
|
Cloning and functional expression of an MIP (AQP0) homolog from killifish (Fundulus heteroclitus) lens. | 2001 Dec |
|
UV-irradiated biodegradability of ethylene--propylene copolymers, LDPE, and I-PP in composting and culture environments. | 2001 Fall |
|
A combined carbon dioxide/erbium laser for soft and hard tissue procedures. | 2001 Jan |
|
Primary donor photo-oxidation in photosystem I: a re-evaluation of (P700(+) - P700) Fourier transform infrared difference spectra. | 2001 Oct 30 |
|
Posttraining administration of gastrin-releasing peptide improves memory loss in scopolamine- and hypoxia-induced amnesic mice. | 2001 Sep 1-15 |
|
Reduced natriuretic response to acute sodium loading in COMT gene deleted mice. | 2002 Aug 21 |
|
Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir. | 2002 Dec |
|
Spontaneous disappearance of refractory viral warts at distant sites following carbon-dioxide laser treatment. | 2002 Dec |
|
Selective detection and assignment of the solution NMR signals of bacteriochlorophyll a in a reconstituted subunit of a light-harvesting complex. | 2002 Feb 13 |
|
Gas-phase ozonolysis of alkenes: formation of OH from anti carbonyl oxides. | 2002 Jul 24 |
|
HPV in "carcinoma in situ" associated with HIV/AIDS infection: a case report. | 2002 Mar-Apr |
|
Chemical inactivation of the cinnamate 4-hydroxylase allows for the accumulation of salicylic acid in elicited cells. | 2002 Oct |
|
Site of nucleophilic attack and ring opening of five-membered heterocyclic 2,3-diones: a density functional theory study. | 2002 Oct 18 |
|
Induction of carbofuran oxidation to 4-hydroxycarbofuran by Pseudomonas sp. 50432. | 2002 Sep 10 |
|
[Effectiveness of ketonal and diclofenac in spondylarthrosis complicated with spinal pain]. | 2003 |
|
Supercritical fluid processing of proteins: lysozyme precipitation from aqueous solution. | 2003 Feb |
|
Can preconditioning reduce laparoscopy-induced tissue injury? | 2003 May |
|
High-sensitivity photoacoustic leak testing. | 2003 Oct |
|
Carbon-dioxide laser-assisted tonsil ablation for adults with chronic tonsillitis: a 6-month follow-up study. | 2003 Sep |
|
Energy cost and cardiorespiratory changes during the practice of Surya Namaskar. | 2004 Apr |
|
Anesthesiological hazards during laparoscopic transhiatal esophageal resection: a case control study of the laparoscopic-assisted vs the conventional approach. | 2004 Aug |
|
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma. | 2004 Dec |
|
Dynamic co-evolution of peptides and chemical energetics, a gateway to the emergence of homochirality and the catalytic activity of peptides. | 2004 Feb |
|
FTIR difference spectroscopy in combination with isotope labeling for identification of the carbonyl modes of P700 and P700+ in photosystem I. | 2004 Feb |
|
Lack of difference in the rates of hypopigmentation with 90-microsecond pulsed and longer dwell time carbon-dioxide laser resurfacing. | 2004 Feb |
|
CO2, not HCO3-, facilitates oxidations by Cu,Zn superoxide dismutase plus H2O2. | 2004 Jan 20 |
|
Supercritical carbon dioxide extraction of selected medicinal plants--effects of high pressure and added ethanol on yield of extracted substances. | 2004 Jan-Feb |
|
Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. | 2004 Jul |
|
Use of CO2/O2 anesthesia in the collection of samples for serum corticosterone analysis from Fischer 344 rats. | 2004 Mar |
|
Hypoxia up-regulates triosephosphate isomerase expression via a HIF-dependent pathway. | 2004 May |
|
Enzymatic reactions in anaerobic 2-methylnaphthalene degradation by the sulphate-reducing enrichment culture N 47. | 2004 Nov 1 |
|
Meerwein-Ponndorf-Verley alkynylation of aldehydes: essential modification of aluminium alkoxides for rate acceleration and asymmetric synthesis. | 2004 Nov 21 |
|
Role of tyrosine phosphorylation in sperm capacitation / acrosome reaction. | 2004 Nov 9 |
|
Metabolism of 2-mercaptobenzothiazole by Rhodococcus rhodochrous. | 2004 Oct |
|
Photochemical preparation of highly functionalized 1-indanones. | 2004 Oct 29 |
|
Difference between diabetic and nondiabetic smokers in the pituitary response to physical exercise. | 2004 Sep |
|
Retention characteristics of porous graphitic carbon in subcritical fluid chromatography with carbon dioxide-methanol mobile phases. | 2004 Sep 3 |
|
Anti-L-selectin antibody therapy does not worsen the postseptic course in a baboon model. | 2005 |
|
Isolation and characterization of a rhodococcus species strain able to grow on ortho- and para-xylene. | 2005 Aug |
|
Physico-chemical characteristics of Anopheles culicifacies and Anopheles varuna breeding water in a dry zone stream in Sri Lanka. | 2005 Jun |
|
Identification of 9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic acid, 4-hydroxy-2-oxohexanoic acid, and 2-hydroxyhexa-2,4-dienoic acid and related enzymes involved in testosterone degradation in Comamonas testosteroni TA441. | 2005 Sep |
|
Pictet-Spengler reactions in multiphasic supercritical carbon dioxide/CO2-expanded liquid media. In situ generation of carbamates as a strategy for reactions of amines in supercritical carbon dioxide. | 2005 Sep 21 |
|
Differentiation of human bone marrow stem cells into cells with a neural phenotype: diverse effects of two specific treatments. | 2006 Feb 16 |
|
Ultrafast transient absorption studies on photosystem I reaction centers from Chlamydomonas reinhardtii. 2: mutations near the P700 reaction center chlorophylls provide new insight into the nature of the primary electron donor. | 2006 Jan 15 |
|
Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice. | 2006 Mar |
|
Characterisation of stationary phases in subcritical fluid chromatography with the solvation parameter model. III. Polar stationary phases. | 2006 Mar 31 |
Patents
Sample Use Guides
Carbon dioxide is usually administered through the lungs by inhalation. The major exceptions are when a metered supply is fed into the oxygenator of an extracorporeal circulation of a cardiopulmonary bypass system, and when the gas is used for laparoscopic surgery. As an additive to beverages, carbon dioxide is consumed orally.
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
16551-4
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
13538-4
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
59165-1
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
28644-3
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
NDF-RT |
N0000180185
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
14640-7
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
51781-3
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
39465-0
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
77143-6
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
NDF-RT |
N0000010258
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
2021-4
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
2020-6
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
35685-7
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
13541-8
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
41647-9
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
2018-0
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
2028-9
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
39464-3
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
32306-3
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
JECFA EVALUATION |
INS-290
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
WHO-ATC |
A06AX02
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
19212-0
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
CFR |
21 CFR 862.1160
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
39466-8
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-290
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
28645-0
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
57920-1
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
53089-9
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
34520-7
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
48391-7
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
2022-2
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
EPA PESTICIDE CODE |
16601
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
2027-1
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
13540-0
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
11557-6
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
38253-1
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
WHO-VATC |
QA06AX02
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
34728-6
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
14040-0
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
57922-7
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
FDA ORPHAN DRUG |
465114
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
57923-5
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
2026-3
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
20565-8
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
DSLD |
3848 (Number of products:1)
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
53458-6
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
57921-9
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
53090-7
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
2019-8
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
19223-7
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
CFR |
21 CFR 184.1240
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
2023-0
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
WHO-VATC |
QV03AN02
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
11211-0
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
LOINC |
14003-8
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
||
|
WHO-ATC |
V03AN02
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4256
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
142M471B3J
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
100000076280
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
DB09157
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
124-38-9
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
DTXSID4027028
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
m3079
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | Merck Index | ||
|
516
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
CHEMBL1231871
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
CARBON DIOXIDE
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
142M471B3J
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
280
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
D002245
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
C65288
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
2034
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB13243MIG
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
16526
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY | |||
|
204-696-9
Created by
admin on Mon Mar 31 18:04:25 GMT 2025 , Edited by admin on Mon Mar 31 18:04:25 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
PARENT (METABOLITE INACTIVE)
PARENT (METABOLITE)